Medical cost inflation in Singapore is on track to hit a record 16.9 per cent in 2026, a sharp escalation that is prompting urgent calls for collective action from the insurance industry. The Life Insurance Association of Singapore (LIA) has sounded the alarm, warning that if left unchecked, the trend could undermine the affordability and sustainability of healthcare for millions of Singaporeans.

A Worrying Trajectory

The projected 16.9 per cent medical cost inflation rate marks a dramatic increase from levels that had stayed below 10 per cent until as recently as 2024. The acceleration has been driven by a combination of factors, including rising specialist fees, increased utilisation of advanced medical technologies, higher drug costs, and the lingering effects of global supply chain disruptions on medical equipment and supplies.

"We are seeing a convergence of cost pressures that is pushing medical inflation to unprecedented levels," said Patrick Teow, president of the LIA. "This is not a problem that any single stakeholder can solve alone. It requires coordinated action from insurers, healthcare providers, regulators, and patients."

What Is Driving the Surge?

Several interconnected factors are behind the record inflation figure. First, the ongoing global energy crisis — exacerbated by the conflict in the Middle East and the closure of the Strait of Hormuz — has driven up transportation and logistics costs for medical supplies and pharmaceuticals. Singapore, which imports the vast majority of its medical equipment and drugs, is particularly exposed to these supply chain pressures.

Second, the rising cost of specialist care in Singapore's private healthcare sector has been a persistent concern. Private hospital bills have increased significantly over the past two years, driven in part by growing demand for elective procedures that were deferred during the COVID-19 pandemic years. The backlog of delayed treatments has created a surge in demand that is pushing prices higher.

Third, advances in medical technology — while improving patient outcomes — are also contributing to higher costs. New cancer treatments, robotic surgical systems, and precision medicine therapies come with substantial price tags that are ultimately passed on to patients and insurers.

Impact on Insurance Premiums

For Singaporeans, the most immediate impact of rising medical costs is likely to be felt through higher insurance premiums. Integrated Shield Plans (IPs), which provide coverage beyond what MediShield Life offers, have already seen multiple rounds of premium increases in recent years. If medical inflation continues at current rates, further premium hikes are considered inevitable.

"Insurance premiums are fundamentally linked to underlying medical costs," explained Dr. Wong Siew Ying, a healthcare economist at the National University of Singapore. "When hospitals charge more, insurers have to pay more, and those costs are eventually passed on to policyholders through higher premiums."

The Ministry of Health (MOH) has acknowledged the challenge and has been working with the industry to implement measures aimed at moderating cost growth. These include the expansion of fee benchmarks for common medical procedures, greater transparency in hospital billing, and the promotion of preventive care to reduce the need for expensive treatments.

What Can Patients Do?

While systemic changes are needed to address the root causes of medical inflation, there are steps individual Singaporeans can take to manage their healthcare costs:

  • Choose restructured hospitals: Public restructured hospitals generally charge lower fees than private facilities for comparable treatments.
  • Use MediSave and MediShield Life: Ensure you understand your coverage and make full use of government healthcare financing schemes.
  • Seek preventive care: Regular health screenings and early intervention can help avoid costly treatments down the line.
  • Compare costs: Use the MOH fee benchmarks website to compare fees for common procedures across different providers.
  • Review your insurance coverage: Ensure your IP rider coverage matches your needs without unnecessary over-insurance that drives up premiums.

Industry Calls for Reform

The LIA has called for a multi-pronged approach to tackle the issue, including greater adoption of evidence-based treatment protocols, expanded use of day surgery where clinically appropriate, and stronger measures to prevent over-servicing. The association has also urged regulators to consider implementing cost control mechanisms that have proven effective in other healthcare systems.

"We are at a critical juncture," said Teow. "If we do not act decisively now, the affordability of healthcare in Singapore — one of the pillars of our social compact — will be seriously compromised."

The Ministry of Health has indicated that it will release a comprehensive review of healthcare cost management measures in the second half of 2026, as Singapore grapples with one of its most pressing domestic challenges.